Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSThree Regulatory News (STEM)

Share Price Information for SThree (STEM)

Share Price is delayed by 15 minutes
Get Live Data
168.80    -1.40 (-0.82%)
Bid:
168.40
Ask:
170.20
Spread: 1.80 (1.069%)
Market Cap: £207.14m
STEM Live PriceLast checked at - London Stock Exchange

Intraday SThree Share Chart

SThree: Board Changes

19 Apr 2022 07:00

SThree (STEM) SThree: Board Changes 19-Apr-2022 / 07:00 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.


19 April 2022

 

 

SThree plc

 

Board Changes

 

 

SThree plc ("SThree" or the "Group"), the only global pure-play specialist staffing business focused on roles in Science, Technology, Engineering and Mathematics ('STEM'), announces that it has received notice from Anne Fahy, Non-Executive Director of the Company, of her resignation from the Board with immediate effect. Accordingly, she will not seek re-election at tomorrow's Annual General Meeting (the "AGM").

 

As the Company's AGM Notice has already been issued, the Company confirms that the resolution to reappoint Anne Fahy as a Non-Executive Director of the Company (Resolution 8) is now withdrawn. The withdrawal of Resolution 8 does not otherwise affect the validity of the Notice of Meeting, or any proxy votes already submitted on other proposed resolutions. The numbering of all other proposed resolutions at the AGM will remain unchanged.

 

The Board and its Committees will now commence a process to select Anne's successor in her role as Non-Executive Director and Chair of the Audit Committee and an announcement will be made in this regard in due course. In the interim period, Barrie Brien will be appointed as Interim Chair of the Audit Committee in respect of any scheduled Committee meetings which may take place before a new Chair is appointed. Barrie brings extensive financial experience, having held the role of Chief Operating and Financial Officer at Creston PLC between 2004 and 2014.

 

James Bilefield, Non-Executive Chair, commented:

 

"On behalf of the Board, I would like to thank Anne for her valued contribution to the Company over many years. She has provided the Group with a wealth of experience during a period which has seen significant growth and expansion. We wish her well for the future."

 

 

- Ends -

 

 

Enquiries:

 

 

SThree plc

 

James Bilefield, Chair

Andrew Beach, CFO

Kate Danson, General Counsel and Group Company Secretary

 

 

 via Alma

Alma PR

+44 20 3405 0205

 

Rebecca Sanders-Hewett

Susie Hudson

SThree@almapr.co.uk

 

 

Notes to editors

SThree plc brings skilled people together to build the future. We are the only global pure-play specialist staffing business focused on roles in Science, Technology, Engineering and Mathematics ('STEM'), providing permanent and flexible contract talent to a diverse base of over 8,000 clients across 14 countries. Our Group's c.2,700 staff cover the Technology, Life Sciences, Engineering and Banking & Finance sectors. SThree is part of the Industrial Services sector. We are listed on the Premium Segment of the London Stock Exchange's Main Market, trading with ticker code STEM.

 


ISIN:GB00B0KM9T71
Category Code:MSCL
TIDM:STEM
LEI Code:2138003NEBX5VRP3EX50
Sequence No.:156114
EQS News ID:1329619
 
End of AnnouncementEQS News Service

UK Regulatory announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
2nd Sep 20242:30 pmRNSChange of Registered Office
2nd Sep 202410:51 amRNSTotal Voting Rights
23rd Aug 202411:00 amRNSBlock listing Interim Review
12th Aug 20242:00 pmRNSDirector/PDMR Shareholding
1st Aug 202411:30 amRNSTotal Voting Rights
23rd Jul 20245:31 pmRNSDirector/PDMR Shareholding
23rd Jul 20247:01 amRNSNotice of Investor Briefing
23rd Jul 20247:00 amRNSFY24 Half Year Results
16th Jul 20247:00 amRNSNotice of Third Investor Briefing
12th Jul 20243:30 pmRNSDirector/PDMR Shareholding
1st Jul 202411:42 amRNSTotal Voting Rights
18th Jun 20247:00 amRNSFY24 Half Year Trading Update
13th Jun 20241:26 pmRNSDirector/PDMR Shareholding
11th Jun 20242:35 pmRNSDirector/PDMR Shareholding
3rd Jun 20249:50 amRNSTotal Voting Rights
13th May 20244:00 pmRNSDirector/PDMR Shareholding
25th Apr 202411:44 amRNSResult of AGM
15th Apr 20243:48 pmRNSDirector/PDMR Shareholding
10th Apr 202412:14 pmRNSChange of Auditor
2nd Apr 202412:10 pmRNSDirectorate Change
22nd Mar 20244:29 pmRNSDirector/PDMR Shareholding
19th Mar 20243:30 pmRNSDirector/PDMR Shareholding
19th Mar 20247:00 amRNSFY24 Q1 Trading Update
14th Mar 202412:11 pmRNSDirector/PDMR Shareholding
12th Mar 20243:59 pmRNSDirector/PDMR Shareholding
7th Mar 20249:20 amRNSDirector/PDMR Shareholding
4th Mar 202410:54 amRNSAnnual Financial Report
23rd Feb 20242:00 pmRNSBlock listing Interim Review
13th Feb 20244:45 pmRNSDirector/PDMR Shareholding
1st Feb 202410:20 amRNSTotal Voting Rights
30th Jan 20247:00 amRNSFY23 Final Results
23rd Jan 20244:25 pmRNSChange of Registrar
15th Jan 20241:19 pmRNSDirector/PDMR Shareholding
18th Dec 20234:56 pmRNSDirector/PDMR Shareholding
14th Dec 202310:58 amRNSDirector/PDMR Shareholding
14th Dec 20237:00 amRNSFY23 Full Year Trading Update
8th Dec 20234:30 pmRNSDirectorate Change
1st Dec 20232:27 pmRNSTotal Voting Rights
23rd Nov 20237:00 amRNSAppointment of Joint Corporate Brokers
16th Nov 202312:41 pmRNSDirector/PDMR Shareholding
14th Nov 20239:45 amRNSHolding(s) in Company
2nd Nov 20232:45 pmRNSTotal Voting Rights
16th Oct 20232:02 pmRNSDirector/PDMR Shareholding
2nd Oct 20233:53 pmRNSTotal Voting Rights
20th Sep 20231:19 pmRNSDirector/PDMR Shareholding
19th Sep 20237:00 amRNSFY23 Q3 Trading Update
13th Sep 202310:35 amRNSDirector/PDMR Shareholding
1st Sep 202312:17 pmRNSTotal Voting Rights
23rd Aug 202311:40 amRNSBlock listing Interim Review
16th Aug 20232:16 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.